Press release
Colorectal Cancer Diagnostics Market Estimated to Accumulate more than US$ 2,000 Mn by 2022
According to the World Cancer Research Fund, colorectal cancer forms the third-most occurring type of cancer across the globe. In 2012, over 1 Mn cases of colorectal cancer were diagnosed. Majority of these cases were reported across developed economies, and this is further estimated to exceed in the near future. This rise in incidences of colorectal cancer has boosted demand for its diagnostics, treatment, and therapeutics worldwide. However, the number of deaths owing to colorectal cancer has been witnessing a decline since recent past, owing to the awareness spread by the American Cancer Society. The introduction of more effective diagnostics, and development of screening methods are further expected to drive growth of the global colorectal cancer diagnostics market.
Request For Report Sample @ www.factmr.com/connectus/sample?flag=S&rep_id=70
The advent of new diagnostic tests, increasing uptakes of diagnosis-associated therapies, and initiatives taken by private as well as government organisations are some factors expected to propel growth of the global market for colorectal cancer diagnostics. Increasing unmet requirements across several emerging economies, coupled with the absence of neoadjuvant and adjuvant pipeline agents for diagnosing high-risk patients affected with resectable colorectal cancer is expected to create huge growth opportunities for leading players in the market. However, factors such as growing reluctance towards medications of colorectal cancer by patients, and unawareness across several remote regions of the globe is expected to inhibit the market growth.
6 Key Projections for the Global Colorectal Cancer Diagnostics Market
North America will continue to be the most lucrative region for the colorectal cancer diagnostics market. Revenue from market in North America is expected to surpass US$ 800 Mn by 2022-end.
The colorectal cancer diagnostics market in Asia Pacific excluding Japan (APEJ) is expected to register the fastest expansion during the forecast period. However, revenue from the market in Middle East & Africa (MEA) will continue to be sluggish during the forecast period.
Click to View Complete Report @ www.factmr.com/connectus/sample?flag=D&rep_id=70
By test type, FOB will continue to be the largest adopted test for diagnosis of colorectal cancer across the globe. Revenue from FOB tests for colorectal cancer diagnostics will remain largest, followed by CTC tests.
Immunochemistry tests for colorectal cancer diagnostics will exhibit the highest CAGR through 2022. However, revenue from BRAF tests will remain the lowest in the global colorectal cancer diagnostics market during the forecast period.
On the basis of end-users, although hospital-associated labs will remain sought-after in the market, cancer research institutes will continue to register the fastest expansion during the forecast period.
Revenues from hospital-associated labs for colorectal cancer diagnostics are expected to reach nearly US$ 1,000 Mn by 2022-end. Independent diagnostic laboratories will continue to be the second most lucrative end-users in the global colorectal cancer diagnostics market.
The report also includes a comprehensive landscape of global market for colorectal cancer diagnostics, where companies namely Illumina, Inc., Foundation Medicine, Inc., Sysmex Corporation, Cancer Genetics, Inc., Danaher Corporation, Biocept, Inc, Pathway Genomics Corporation, Rosetta Genomics, Epigenomics AG, and Exact Science Corporation are profiled.
Click to View Complete Report @ www.factmr.com/report/70/colorectal-cancer-diagnostics-market
About Us
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Fact.MR
Office: Dublin 2
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Tel: +353-1-6111-593
( Dublin 2 )
Email: sales@factmr.com
Web: www.factmr.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Colorectal Cancer Diagnostics Market Estimated to Accumulate more than US$ 2,000 Mn by 2022 here
News-ID: 704901 • Views: …
More Releases from Fact.MR
Sales of Luxury Eyewear are forecasted to reach US$ 56 billion by 2033
According to Fact.MR, a trusted provider of market research and competitive intelligence, the global Luxury Eyewear Market was valued at US$ 40 billion in 2023. Projections suggest that by the conclusion of 2033, this market is anticipated to escalate to US$ 56 billion. Forecasts indicate a steady Compound Annual Growth Rate (CAGR) of 3.4% in the global demand for luxury eyewear from 2023 to 2033.
The surge in luxury eyewear sales…
Camping Equipment sales are expected to reach US$ 33.17 billion By 2032
The global camping equipment market is projected to achieve a substantial value of US$ 33.17 billion by the year 2032, exhibiting a commendable Compound Annual Growth Rate (CAGR) of 7.3% from 2022 to 2032. A surge in expenditure on outdoor recreational activities is poised to ignite significant growth within the camping equipment market.
According to insights from Fact.MR, the global camping equipment market is forecasted to reach a valuation of US$…
Microbial Algae Products is forecasted to expand at a CAGR of 6.1% from 2024 to …
The global microbial algae product market is set to expand at a compound annual growth rate (CAGR) of 6.1%, as outlined in the latest industry research report by Fact.MR. By the end of 2034, the market is anticipated to surge from US$ 3.43 billion in 2024 to US$ 6.2 billion.
Recent years have witnessed a notable surge in demand for microbial algae products due to their rich nutritional profile, comprising minerals,…
Life Insurance Policy Administration System market is projected to rise at a CAG …
As per a recent study conducted by Fact.MR, a reputable market research and competitive intelligence firm, the global Life Insurance Policy Administration System Market is poised to grow at a robust Compound Annual Growth Rate (CAGR) of 12.2% until the year 2034. The market is forecasted to achieve a valuation of US$ 6,689.2 million by the end of 2024, with further projections indicating a potential surge to US$ 21,115.2 million…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview
Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports.
This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
This report focuses on top…
